Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated133%
withdrawn133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

NCT01426516
completednot_applicable

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay

NCT01507155
withdrawnnot_applicable

An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression

NCT01438242

Clinical Trials (3)

Showing 3 of 3 trials
NCT01426516Not Applicable

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

Terminated
NCT01507155Not Applicable

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay

Completed
NCT01438242Not Applicable

An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3